QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 0.11
-- x --
-- x --
-- - --
$ 0.09 - $ 5.10
24,539
na
7.6M
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-27-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 04-14-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 prosomnus-q4-sales-784m-beat-737m-estimate

ProSomnus (NASDAQ:OSA) reported quarterly sales of $7.84 million which beat the analyst consensus estimate of $7.37 million by ...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

 top-4-health-care-stocks-that-are-preparing-to-pump-this-month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 prosomnus-reports-successful-pilot-study-validation-of-next-generation-remote-patient-monitoring-device-for-obstructive-sleep-apnea

ProSomnus, Inc. (NASDAQ:OSA) (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced re...

 alliance-global-partners-initiates-coverage-on-prosomnus-with-buy-rating-announces-price-target-of-2

Alliance Global Partners analyst Scott Henry initiates coverage on ProSomnus (NASDAQ:OSA) with a Buy rating and announces Pr...

 prosomnus-comments-on-insurance-coverage-policy-update-for-obstructive-and-central-sleep-apnea

ProSomnus, Inc. (NASDAQ:OSA) (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the...

 why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

 why-is-sleep-devices-focused-prosomnus-stock-soaring-today

ProSomnus Inc (NASDAQ: OSA) announced the publication of a study by the Cureus Journal of Medical Science, highlighting the com...

 prosomnus-inc-announces-data-published-by-cureus-journal-of-medical-science-shows-successful-treatment-of-obstructive-sleep-apnea-with-prosomnus-precision-oral-appliance-devices

ProSomnus, Inc. (NASDAQ:OSA) (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announ...

 why-salesforce-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket

Shares of Salesforce, Inc.

 prosomnus-shares-resume-trade
ProSomnus Shares Resume Trade
11/29/2023 19:58:11

 craig-hallum-downgrades-prosomnus-to-hold-announces-1-price-target

Craig-Hallum analyst Alexander Nowak downgrades ProSomnus (NASDAQ:OSA) from Buy to Hold and announces $1 price target.

 prosomnus-q3-2023-eps-070-misses-034-estimate-sales-707m-beat-703m-estimate

ProSomnus (NASDAQ:OSA) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.34) by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION